Press Releases March 31, 2026

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

OrthoPediatrics Announces Participation in Upcoming Needham Virtual Healthcare Conference

By Marcus Reed KIDS
OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
KIDS

OrthoPediatrics Corp., a pediatric orthopedic device company, announced that its President & CEO Dave Bailey and COO & CFO Fred Hite will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026. The event will be webcast live with replays available on the company's investor relations website.

Key Points

  • OrthoPediatrics focuses exclusively on pediatric orthopedics with a comprehensive product portfolio spanning trauma, deformity, scoliosis, and sports medicine.
  • The company markets over 85 pediatric orthopedic products globally, distributing in the U.S. and more than 75 countries outside the U.S.
  • Leadership engagement in investor conferences helps increase company visibility and investor relations efforts.

WARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference.

Event: 25th Annual Needham Virtual Healthcare Conference
Format: Fireside Chat
Date: Tuesday, April 14, 2026
Time: 9:30 am ET

An audio webcast of the discussions will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
[email protected] 
415-937-5406


Risks

  • No new operational or financial results disclosed, limiting immediate impact on investment decision-making.
  • Market and regulatory challenges in the pediatric orthopedic device space remain ongoing uncertainties.
  • Global distribution and reliance on international markets may expose the company to geopolitical and supply chain risks.

More from Press Releases

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders Apr 3, 2026 Midland States Bancorp, Inc. To Announce First Quarter 2026 Financial Results On Thursday, April 23 Apr 3, 2026 Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 3, 2026 Multi-Sensor Data Labeling and AI Data Operations: What Enterprise AV Teams Apr 3, 2026 Wix Announces Final Results of Modified Dutch Auction Tender Offer Apr 3, 2026